Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging. Read more about Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging.
Defining the prevalence of inherited DNA damage repair genetic variants (DDRv) in men with prostate cancer (PCa) detected by PSMA PET. Read more about Defining the prevalence of inherited DNA damage repair genetic variants (DDRv) in men with prostate cancer (PCa) detected by PSMA PET.
The cognitive load of inpatient consults involving immune-related adverse events. Read more about The cognitive load of inpatient consults involving immune-related adverse events.
Delayed immune toxicities in patients with breast cancer receiving immune checkpoint inhibitors. Read more about Delayed immune toxicities in patients with breast cancer receiving immune checkpoint inhibitors.
Longitudinal, prospective cardiovascular and metabolic risk in treatment-naive patients with chronic myeloid leukemia in chronic phase (CML-CP) starting tyrosine kinase inhibitor (TKI) therapy in a real-world setting. Read more about Longitudinal, prospective cardiovascular and metabolic risk in treatment-naive patients with chronic myeloid leukemia in chronic phase (CML-CP) starting tyrosine kinase inhibitor (TKI) therapy in a real-world setting.
Should I stay, or should I go? Factors associated with intent to leave academic oncology. Read more about Should I stay, or should I go? Factors associated with intent to leave academic oncology.
Detection of early-stage cancers using circulating orphan non-coding RNAs in blood. Read more about Detection of early-stage cancers using circulating orphan non-coding RNAs in blood.
Consensus molecular subtypes and orphan non-coding RNAs in colorectal cancer. Read more about Consensus molecular subtypes and orphan non-coding RNAs in colorectal cancer.
Feasibility and acceptability of social determinants of health data collection in the context of a Children’s Oncology Group trial. Read more about Feasibility and acceptability of social determinants of health data collection in the context of a Children’s Oncology Group trial.
Phase II trial of neoadjuvant osimertinib for surgically resectable EGFR -mutated non-small cell lung cancer. Read more about Phase II trial of neoadjuvant osimertinib for surgically resectable EGFR -mutated non-small cell lung cancer.
